Poseida Therapeutics poseida.com


Public list: Synthetic Biology (133) Pharma Startups (4500)

Poseida is a therapeutics-focused biotechnology company using best-in-class genome engineering technologies to develop novel, life-saving treatments, including gene therapies for orphan liver diseases and immuno-oncology therapeutics for several types of cancer. Poseida's lead product candidates include a gene therapy treatment for the rare liver disease Progressive Familial Intraheptatic Cholestasis 3 and an autologous CAR-T therapeutic for multiple myeloma. Poseida is also partnered with Janss...Show all

Poseida is a therapeutics-focused biotechnology company using best-in-class genome engineering technologies to develop novel, life-saving treatments, including gene therapies for orphan liver diseases and immuno-oncology therapeutics for several type...Show all

Company (Alive / Active)

Phone: 858-242-1576

Fax:

4250 Executive Square
Suite 900
La Jolla, 92037
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Poseida Therapeutics $30M Dec 16, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Poseida Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hyperactive piggybac transposases Feb 22, 2013 Jan 17, 2017 Patent
A method for directing proteins to specific loci in the genome and uses thereof Jun 17, 2015 Application
Methods and compositions for in vivo non-covalent linking Jun 17, 2015 Application